ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:11 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 282
Drug details and screening numbers
Drug Name: EKB-569
Drug ID: 282
Synonyms: Pelitinib
Brand name:
Target: EGFR
Number of cell lines screened: 923
Screening concentration range(s): 0.009765625 to 2.5 uM and 0.078125 to 20 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a348 |
loss_cnaPANCAN131 |
282 |
1 |
1 |
EKB-569 |
EGFR |
18 |
902 |
0.916, 2.996 |
1.49 |
2.56 |
1.07 |
0.62 . |
0.62 . |
0.82 . |
3.45e-04 |
6.41e-29 |
8.98e-01 |
16 |
All-tests volcano plot